Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis
- 1 December 1997
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 23 (3), 380-394
- https://doi.org/10.1006/bcmd.1997.0155
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996
- Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.The Journal of Experimental Medicine, 1996
- Structural and Signaling Requirements for BCR-ABL-Mediated Transformation and Inhibition of ApoptosisMolecular and Cellular Biology, 1995
- Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogeneCell, 1995
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Structural organization of the bcr gene and its role in the Ph′ translocationNature, 1985
- A new leukemia cell line with philadelphia chromosome characterized as basophil precursorsLeukemia Research, 1985
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984
- Establishment of a Ph 1 chromosome‐positive cell line from chronic myelogenous leukemia in blast crisisThe International Journal of Cell Cloning, 1983
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975